Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 11,000 shares at $41.39 ($461K) on 2024-01-22, disclosed to the SEC on 2024-01-24.
Scheduled sale ($461k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.39 | 2,500 | $103K | 22.4% |
| 2 | $42.05 | 3,000 | $126K | 27.4% |
| 3 | $42.05 | 3,000 | $126K | 27.4% |
| 4 | $42.06 | 2,500 | $105K | 22.8% |
| Total | $41.90 avg | 11,000 | $461K | 100% |
| Filing → |
| VCEL | SELL | 2024-11-13 | $281K | — | Filing → |
| VCEL | SELL | 2024-03-29 | $338K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |